cell therapies - International Biopharmaceutical Industry

Current Edition

Volume 4 Issue 3

Regulatory Challenges Associated with the Development of Cell and Gene Therapies

The development of safe and effective cell and gene therapies (CGTs) relies on regulatory compliance and critical selection and qualification of raw materials. Regula...

1 September 2021 Volume 4 Issue 3 cell and gene therapies | cell therapies

Continue Reading →

news

Gilead’s Kite bets on early-stage biotech to advance allogeneic cell therapies

The deal with Appia is yet another step in Gilead’s efforts to become an oncology powerhouse — a strategy the company has made clear through numerous acquisitions and...

13 August 2021 news allogeneic cell therapies | Biotech

Continue Reading →

International Biopharmaceutical Industry

IBI – International Biopharmaceutical Industry was established to fill in the void for effective marketing and communication between all stakeholders in the Life sciences sector globally.

Current Edition

Upcoming Events

Advertisement

Regulatory Challenges Associated with the Development of Cell and Gene Therapies

Gilead’s Kite bets on early-stage biotech to advance allogeneic cell therapies

International Biopharmaceutical Industry